First Foundation Advisors’s Emmaus Life Sciences, Inc. Common Stock EMMA Stock Holding History

First Foundation Advisors’s Portfolio EMMA Stock Details EMMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,667	Closed	-$21K	–	376
2019 Q2	$21K	Hold	2,667	–	–	﹤0.01%	345
2019 Q1	$22K	Hold	2,667	–	–	﹤0.01%	330
2018 Q4	$12K	Hold	2,667	–	–	﹤0.01%	378
2018 Q3	$25K	Hold	2,667	–	–	﹤0.01%	356
2018 Q2	$29K	Hold	2,667	–	–	﹤0.01%	331
2018 Q1	$19K	Hold	2,667	–	–	﹤0.01%	319
2017 Q4	$54K	Hold	2,667	–	–	﹤0.01%	321
2017 Q3	$61K	Buy	+2,667	New	+$62K	﹤0.01%	301

Other funds holding EMMA

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

First Foundation Advisors's EMMA Position: Q3 2019 in Review

First Foundation Advisors sold out of Emmaus Life Sciences, Inc. Common Stock (EMMA) in Q3 2019, closing a stake of 2,667 shares — an estimated $21K sold.

First Foundation Advisors first reported a position in EMMA in Q3 2017 and held it in 8 quarters. The position peaked at $61K in Q3 2017. 1 fund tracked by Wall St. Rank holds EMMA as of Q3 2019.

First Foundation Advisors reported no remaining Emmaus Life Sciences, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
First Foundation Advisors sold 2,667 Emmaus Life Sciences, Inc. Common Stock shares in Q3 2019, an estimated $21K.
First Foundation Advisors first reported a position in Emmaus Life Sciences, Inc. Common Stock in Q3 2017 and held it in 8 quarters.
First Foundation Advisors's Emmaus Life Sciences, Inc. Common Stock position peaked at $61K in Q3 2017.
1 fund tracked by Wall St. Rank held Emmaus Life Sciences, Inc. Common Stock as of Q3 2019.

Based on First Foundation Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.